Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

24th Virtual Meeting of the National Cancer Advisory Board - Meeting Agenda

September 2, 2026

Virtual Subcommittee Meetings

Time: 9:30 am to 12:00 pm EDT
NIH Videocast: Meeting Videocast

September 2 Agenda - Open Session
TimePresentation TopicPresenter
9:30 am - 10:30 amAd Hoc Subcommittee on Experimental Therapeutics
10:40 am - 11:40 amAd Hoc Subcommittee on Population Science, Epidemiology, and Disparities
11:40 am - 12:00 pmAdjournment and Break

Virtual NCAB Meeting

Time: 12:00 pm to 4:30 pm EDT
NIH Videocast: Meeting Videocast

September 2 Agenda - Open Session
TimePresentation TopicPresenter
12:00 pm - 12:05 pm

Call to Order and Opening Remarks

  • Consideration of June 2026 NCAB Meeting Summary
  • Conflict of Interest
  • Future Meeting Dates

Confirmed Dates:
December 1-2, 2026 (Tuesday and Wednesday)
February 11, 2027 - Virtual (Thursday)
June 9-10, 2027 (Wednesday and Thursday)
September 1, 2027 - Virtual (Wednesday)
December 1-2, 2027 (Wednesday and Thursday)
February 10, 2028 - Virtual (Thursday)
June 7-8, 2028 (Wednesday and Thursday)
September 13, 2028 - Virtual (Wednesday)
December 5-6, 2028 (Tuesday, Wednesday)

Dr. Carpten
12:05 pm - 12:45 pmNCI Director's RemarksDr. Letai
12:45 pm - 1:45 pm

NCI Support for Cancer Research Training and Workforce Excellence

Dr. Zahir & Dr. Calzola
1:45 pm - 2:00 pmNotice of Funding Opportunity (NOFO) UpdatesDr. Chen
2:00 pm - 2:30 pmScientific Presentation - Advances in Primary and Secondary Prevention of Human papillomavirus (HPV) Related CancersDr. Castle
2:30 pm - 3:30 pm
3:30 pm - 3:40 pmAdjournment and Break
September 2 Agenda - Closed Session
TimePresentation TopicPresenter
3:40 pm - 4:30 pm

This portion of the meeting is being closed to the public in accordance with the Provisions set forth in Sections 552b(c) (4), 552b(c) (6). Title 5 U.S. Code and 10(d) of The Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2).

  • Call to Order and Opening Remarks - Dr. Carpten
  • Grants Review - Dr. Feiese
  • Discussion of Personnel and Proprietary Issues
4:30 pmAdjournment
  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “24th Virtual Meeting of the National Cancer Advisory Board - Meeting Agenda was originally published by the National Cancer Institute.”

Email